The report on global anticoagulant market provides qualitative and quantitative analysis for the period of 2016 to 2024. The report predicts the global anticoagulant market to grow with a CAGR of 6.9% over the forecast period of 2018-2024. The study on anticoagulant market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.
Global Anticoagulant market is showing a positive trend of growth around the globe. There are many factors which are indicating a positive outlook of this market for medium and long term. The increasing aging population is a key driver for the global anticoagulants market. Also, increasing investment in R&D in the pharmaceutical sector and the introduction of innovative oral anticoagulants drugs are expediting the growth of this market. Stringent regulations implemented by many governments for health safety reason could hamper the growth of the global anticoagulants market in short and medium term. Moreover, risk of side-effects and complications associated with anticoagulants also hinders growth of the global anticoagulants market. Moreover, due to increasing awareness about therapeutic applications of anticoagulants in different disease among the physicians and surgeons around the globe could further drive the market globally.
On the basis of region, the Anti-coagulant market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America dominates the global anticoagulants market. Asia region is expected to grow at the fastest CAGR during the forecast period. China and India are the major countries responsible for driving growth in the Asia Pacific region due to increasing demand for better medical infrastructure, increasing healthcare spending among middle and working class people and governments initiatives to provide better health care services to its citizens. Furthermore, rising awareness about the use of anti-coagulant medicine and therapy among physicians, doctors and common persons, are some major driving force of the anticoagulant market in these regional segment.
The report on anticoagulant market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global anticoagulant market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global anticoagulant market over the period of 2016 to 2024. Further, the Growth Matrix h Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.
Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents.
The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through:
1. Key Opinion Leaders associated
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers
Primary research respondents typically include:
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
Secondary sources of the data typically include:
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
The global anticoagulant market is segmented on the basis of roa, anticoagulant drugs, applications and drug class.
Global Anticoagulant Market by ROA
- Oral Anticoagulants
- Injectable Anticoagulants
Global Anticoagulant Market by Anticoagulant Drugs
- Dabigatran (Pradaxa)
- Edoxaban, Rivaroxaban (Xarelto)
- Eliquis (Apixaban)
Global Anticoagulant Market by Applications
- Cardiovascular Diseases
- Coronary Artery Diseases
- Cardiac Arrhythmia
- Myocardial Infarction
- Heart Valve Replacement
Global Anticoagulant Market by Drug Class
- Factor Xa Inhibitors
- Vitamin K Antagonists
- Johnson & Johnson
- Eli Lilly
- Keryx Biopharmaceuticals
- LEO Pharma
- The Medicines Company
- Bayer HealthCare
- Boehringer Ingelheim
How this report delivers
1. Comprehensive analysis of global as well as regional markets of anticoagulant market.
2. Complete coverage of all the segments in anticoagulant market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in global anticoagulant market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Global Anticoagulant Market Overview
3.2. Market Dynamics
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.5. Competitive Landscape in the Global Anticoagulant Market
4. Global Anticoagulant Market by ROA
4.1. Oral Anticoagulants
4.2. Injectable Anticoagulants
5. Global Anticoagulant Market by Anticoagulant Drugs
5.2. Dabigatran (Pradaxa)
5.3. Edoxaban, Rivaroxaban (Xarelto)
5.4. Eliquis (Apixaban)
6. Global Anticoagulant Market by Applications
6.1. Cardiovascular Diseases
6.2. Coronary Artery Diseases
6.3. Cardiac Arrhythmia
6.4. Myocardial Infarction
6.6. Heart Valve Replacement
7. Global Anticoagulant Market by Drug Class
7.1. Factor Xa Inhibitors
7.4. Vitamin K Antagonists
8. Global Anticoagulant Market by Region 2016-2024
8.1. North America
8.1.1. North America Anticoagulant Market by ROA
8.1.2. North America Anticoagulant Market by Anticoagulant Drugs
8.1.3. North America Anticoagulant Market by Applications
8.1.4. North America Anticoagulant Market by Drug Class
8.1.5. North America Anticoagulant Market by Country
8.2.1. Europe Anticoagulant Market by ROA
8.2.2. Europe Anticoagulant Market by Anticoagulant Drugs
8.2.3. Europe Anticoagulant Market by Applications
8.2.4. Europe Anticoagulant Market by Drug Class
8.2.5. Europe Anticoagulant Market by Country
8.3.1. Asia-Pacific Anticoagulant Market by ROA
8.3.2. Asia-Pacific Anticoagulant Market by Anticoagulant Drugs
8.3.3. Asia-Pacific Anticoagulant Market by Applications
8.3.4. Asia-Pacific Anticoagulant Market by Drug Class
8.3.5. Asia-Pacific Anticoagulant Market by Country
8.4.1. RoW Anticoagulant Market by ROA
8.4.2. RoW Anticoagulant Market by Anticoagulant Drugs
8.4.3. RoW Anticoagulant Market by Applications
8.4.4. RoW Anticoagulant Market by Drug Class
8.4.5. RoW Anticoagulant Market by Sub-region
9. Company Covered
9.1. Johnson & Johnson
9.4. Eli Lilly
9.5. Keryx Biopharmaceuticals
9.6. Leo Pharma
9.8. The Medicines Company
9.9. Bayer Healthcare
9.10. Boehringer Ingelheim